Regent Surgical Health, Conformis partner to cut ASC joint replacement costs

Rachel Popa - Print  |

Medical technology company Conformis has entered into a partnership focusing on outpatient joint replacements with ASC developer Regent Surgical Health.

The companies will work together to reduce cost and improve the outcomes of total joint replacement procedures. Conformis develops and sells customized implants for joint replacement surgery.

"Conformis has transformed joint replacement technology, which has led to better patient outcomes," said Regent Surgical Health CEO Chris Bishop. "Our collaboration builds on that and allows us to improve clinical pathways for patients while enhancing the value proposition for surgeons, employers and payers."

Regent operates 26 ASCs, 21 hospital joint ventures, 14 total joint replacement centers and three bundled-payment entities.

"It is clear that payers and providers want to establish a business and clinical care model that results in better patient outcomes and enables delivery of total joint arthroplasty resulting in overall lower cost of care," said Conformis CEO Mark Augusti.

More articles on orthopedics and TJR:
ASC total joint program bundles, vendors & more — 3 insights from an administrator
3 ASCs adding surgical robots
More efficient anterior hip replacements: the role of orthopedic tables

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.